|Project Title||A Protocol for Active Surveillance of Acute Myocardial Infarction in Association with the use of a New Antidiabetic Pharmaceutical Agent|
Wednesday, January 18, 2012
This article describes a protocol for active surveillance of acute myocardial infarction (AMI) in users of a recently approved oral antidiabetic medication, saxagliptin, along with several comparators, and provides the rationale for decisions made in drafting the protocol.
oral antidiabetic medication
acute myocardial infarction (AMI)
|Population / Cohort||
- Vaccines, Blood & Biologics
- Devices and Radiologic Health